Connect with MMS

MMS is the leading data-focused CRO dedicated to supporting your needs. To request more information or to speak with a representative from MMS, please use this form and one of our colleagues will contact you shortly.

MMS locations map
North America
MMS Holdings Inc.
6880 Commerce Blvd.
Canton, MI 48187, USA
info@mmsholdings.com
Asia
MMSH Clinical Research Pvt. Ltd.
2/1, Dr. Rajkumar Road,
Rajajinagar
Bangalore 560010, India
Asia@mmsholdings.com
Europe
Scottish Provident Building
3rd Floor Office,
Scottish Provident Building,
7 Donegall Square West,
Belfast, BT1 6JH
United Kingdom
Europe@mmsholdings.com
South Africa
Postnet Preller Suite 3
Private Bag X01
Heuwelsig 9332, Bloemfontein
South Africa
 SA@mmsholdings.com
Asia
Sonthalia (Dwaraka)
Mindspace, Suite 401,
Madhapur Hyderabad 500081
India
Asia@mmsholdings.com

Suggested For You

webinar

December 4th, 2025

Writing with Quality Control in Mind: A Cross-functional Approach 

webinar

June 26th, 2025

De-Risking Development with Specialized Data Strategies: From Trial Design to Submission

perspectives

November 4th, 2025

4 Key Takeaways from the EMA - Health Canada Joint Review Process and Evaluation of Its Efficiency

perspectives

October 28th, 2025

New Updates on Clinical Trial Transparency and Regulatory Requirements: A Comprehensive Overview 

webinar

October 21st, 2025

A Practical Guide to Expedited Regulatory Pathways

perspectives

October 21st, 2025

Shaping Clinical Development Through Writing: Francesca’s Journey at MMS 

news

October 16th, 2025

MMS Named Finalist in the Fierce Life Sciences Innovation Awards for KerusCloud® Clinical Trial Simulation Platform 

perspectives

October 14th, 2025

CRO Partnerships and Biotech Agility: How Smaller Sponsors Gain Speed in Clinical Development  

perspectives

October 7th, 2025

From Academia to Building Medical Writing Partnerships: Jessica Murdock’s MMS Story  

news

October 2nd, 2025

MMS Announces Its Role in Supporting Gates Ventures and the GNPC to Deliver One of the World's Largest Proteomic Datasets for Neurodegenerative Diseases

perspectives

September 30th, 2025

Ready by Design: Endpoints, Feasibility, and Scenario Testing

news

September 24th, 2025

MMS Named Finalist in Citeline’s 2025 Scrip Awards for Best Contract Research Organization (CRO) – Specialist Providers